TransMedics Group, Inc. - Common Stock (TMDX)
Healthcare › Electromedical & Electrotherapeutic Apparatus
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 327% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 18.8% — good return on equity
- Revenue growing at 37% annually
TransMedics Group, Inc. - Common Stock (TMDX) is a Healthcare company operating in Electromedical & Electrotherapeutic Apparatus, listed on the NASDAQ , with a market capitalisation of $4.2 billion . Key value metrics: P/E ratio 46.7, P/B ratio 8.80, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
TransMedics Group, Inc. - Common Stock — Fundamental Analysis Summary
TransMedics Group, Inc. - Common Stock (TMDX) is currently trading 327% above its Graham Number of $28.39, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 46.7x.
On financial health, TMDX shows a moderate Piotroski F-Score of 5/9, and solid return on equity of 18.8% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.12.
StockPik's composite Value Score for TMDX is 57/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
TMDX reports a solid gross margin of 59.7% (sector average: 33.5%) and a solid operating margin of 16.5%.
TMDX shows revenue growing at 37% year-over-year, with earnings growing at 437%.